Cargando…
Editorial: JAK inhibition in autoimmune and inflammatory diseases
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832019/ https://www.ncbi.nlm.nih.gov/pubmed/36643918 http://dx.doi.org/10.3389/fimmu.2022.1120281 |
_version_ | 1784867971865247744 |
---|---|
author | Telliez, Jean-Baptiste Gadina, Massimo Ghoreschi, Kamran Silvennoinen, Olli Spinelli, Francesca Romana |
author_facet | Telliez, Jean-Baptiste Gadina, Massimo Ghoreschi, Kamran Silvennoinen, Olli Spinelli, Francesca Romana |
author_sort | Telliez, Jean-Baptiste |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9832019 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98320192023-01-12 Editorial: JAK inhibition in autoimmune and inflammatory diseases Telliez, Jean-Baptiste Gadina, Massimo Ghoreschi, Kamran Silvennoinen, Olli Spinelli, Francesca Romana Front Immunol Immunology Frontiers Media S.A. 2022-12-28 /pmc/articles/PMC9832019/ /pubmed/36643918 http://dx.doi.org/10.3389/fimmu.2022.1120281 Text en Copyright © 2022 Telliez, Gadina, Ghoreschi, Silvennoinen and Spinelli https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Telliez, Jean-Baptiste Gadina, Massimo Ghoreschi, Kamran Silvennoinen, Olli Spinelli, Francesca Romana Editorial: JAK inhibition in autoimmune and inflammatory diseases |
title | Editorial: JAK inhibition in autoimmune and inflammatory diseases |
title_full | Editorial: JAK inhibition in autoimmune and inflammatory diseases |
title_fullStr | Editorial: JAK inhibition in autoimmune and inflammatory diseases |
title_full_unstemmed | Editorial: JAK inhibition in autoimmune and inflammatory diseases |
title_short | Editorial: JAK inhibition in autoimmune and inflammatory diseases |
title_sort | editorial: jak inhibition in autoimmune and inflammatory diseases |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832019/ https://www.ncbi.nlm.nih.gov/pubmed/36643918 http://dx.doi.org/10.3389/fimmu.2022.1120281 |
work_keys_str_mv | AT telliezjeanbaptiste editorialjakinhibitioninautoimmuneandinflammatorydiseases AT gadinamassimo editorialjakinhibitioninautoimmuneandinflammatorydiseases AT ghoreschikamran editorialjakinhibitioninautoimmuneandinflammatorydiseases AT silvennoinenolli editorialjakinhibitioninautoimmuneandinflammatorydiseases AT spinellifrancescaromana editorialjakinhibitioninautoimmuneandinflammatorydiseases |